- Home
- DDS vs AXSM Comparison
DDS vs AXSM Comparison
Compare DDS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDS
- AXSM
- Stock Information
- Founded
- DDS 1938
- AXSM 2012
- Country
- DDS United States
- AXSM United States
- Employees
- DDS N/A
- AXSM N/A
- Industry
- DDS Department/Specialty Retail Stores
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- DDS Consumer Discretionary
- AXSM Health Care
- Exchange
- DDS Nasdaq
- AXSM Nasdaq
- Market Cap
- DDS 5.0B
- AXSM 4.8B
- IPO Year
- DDS N/A
- AXSM 2015
- Fundamental
- Price
- DDS $336.90
- AXSM $106.27
- Analyst Decision
- DDS Sell
- AXSM Strong Buy
- Analyst Count
- DDS 2
- AXSM 15
- Target Price
- DDS $326.00
- AXSM $171.00
- AVG Volume (30 Days)
- DDS 161.9K
- AXSM 884.0K
- Earning Date
- DDS 05-15-2025
- AXSM 05-05-2025
- Dividend Yield
- DDS 0.30%
- AXSM N/A
- EPS Growth
- DDS N/A
- AXSM N/A
- EPS
- DDS 36.82
- AXSM N/A
- Revenue
- DDS $6,590,231,000.00
- AXSM $385,693,000.00
- Revenue This Year
- DDS N/A
- AXSM $63.52
- Revenue Next Year
- DDS N/A
- AXSM $63.32
- P/E Ratio
- DDS $9.02
- AXSM N/A
- Revenue Growth
- DDS N/A
- AXSM 42.53
- 52 Week Low
- DDS $282.24
- AXSM $64.11
- 52 Week High
- DDS $510.00
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- DDS 49.04
- AXSM 46.35
- Support Level
- DDS $316.79
- AXSM $103.15
- Resistance Level
- DDS $338.29
- AXSM $106.05
- Average True Range (ATR)
- DDS 17.16
- AXSM 5.05
- MACD
- DDS 4.85
- AXSM 0.95
- Stochastic Oscillator
- DDS 97.52
- AXSM 97.32
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.